Prostate cancer (CaP) is the most commonly diagnosed non-cutaneous cancer and the
second leading cause of male cancer deaths in the United States. Among African American …

Despite more aggressive screening across all demographics and gradual declines in
mortality related to prostate cancer (PCa) in the United States, race disparities persist. For …

Prostate cancer is the most common non-skin cancer and the second leading cause of
cancer-related death for men in the United States. Prostate cancer incidence and associated …

Purpose: The aim of this study was to compare the frequency of ERG rearrangement, PTEN
deletion, SPINK1 overexpression, and SPOP mutation in prostate cancer in African …

In the past 20 years, new insights into the genomic pathogenesis of prostate cancer have
been provided. Large-scale integrative genomics approaches enabled researchers to …

Prostate cancer is the most frequently diagnosed and second most fatal nonskin cancer
among men in the United States. African American men are two times more likely to develop …

Prostate cancer (PCa) is the second most frequently diagnosed malignancy and the second
leading cause of death in men worldwide, after adjusting for age. According to the …

Prostate cancer (PCa) is the second leading cause of cancer-related deaths in the United
States. The African (AA) descent has greater incidence and mortality rates of PCa as …

Abstract Purpose: African American (AFR) men have the highest mortality rate from prostate
cancer (PCa) compared with men of other racial/ancestral groups. Differences in the …

Prostate cancer is the second most common cancer in men in the United States, and racial
disparities are greatly observed in the disease. Specifically, African American (AA) patients …